Back

Impact of beta-blocker therapy in patients with preserved left ventricular ejection fraction after ST-segment elevation myocardial infarction

11 May 2024 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: Chronic heart failure - treatment 13 Pharmacotherapy HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Catarina Carvalho

ULSAM - Hospital de Santa Luzia, Viana do Castelo (Portugal)

4 More presentations in this session

Presentation thumbnail
Effects of sodium-glucose cotransporter 2 inhibitors on pulmonary hemodynamics in chronic heart failure patients and a pulmonary artery pressure sensor: does left ventricular ejection fraction matter?
Doctor E. Santiago-Vacas (Badalona, ES)
Abstract Slides Video
Presentation thumbnail
Impact of the guideline-directed medical therapy on the eligibility of patients for mitral valve transcatheter edge-to-edge repair in HFrEF
Doctor B. Muk (Budapest, HU)
Abstract Slides Video
Presentation thumbnail
Beyond assumptions: NT-proBNP rise and diuretic strategies in HFrEF therapy up-titration
Doctor D. Ferreira (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
Initial 6-hour injectable diuretic therapy on 24-month outcomes in acute heart failure patients
Doctor A. Singh (Manipal, IN)
Abstract Slides Video

Access the full session

Session thumbnail
Chronic heart failure - treatment 13

The Event

Event poster

Heart Failure 2024

11 May - 14 May 2024
You may be interested in
thumbnail
Congress Presentation
Impact of beta-blocker Nebivolol versus Carvedilol prescription at discharge on long-term clinical outcomes in STEMI patients with preserved LVEF treated with drug-eluting stents
thumbnail
Congress Presentation
Mortality effects of beta-blockers on myocardial infarction in patients without reduced ejection fraction or heart failure in the contemporary reperfusion era : a systematic review and meta-analysis
thumbnail
Congress Presentation
Beta-blocker duration and long-term cardiovascular risk after myocardial infarction with reduced ejection fraction

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources